Movement disorders in patients with alternating hemiplegia
“Soft” and “stiff” at the same time
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 24, 2019
- Accepted in final form September 24, 2019
- First Published March 2, 2020.
Article Versions
- Previous version (March 2, 2020 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Eleni Panagiotakaki, MD,
- Diane Doummar, MD,
- Erika Nogue, MSc,
- Nicolas Nagot, MD, PhD,
- Gaetan Lesca, MD, PhD,
- Florence Riant, PhD,
- Sophie Nicole, PhD,
- Charlene Delaygue, MSc,
- Marie Anne Barthez, MD,
- Marie Cécile Nassogne, MD, PhD,
- Anne Dusser, MD,
- Louis Vallée, MD,
- Thierry Billette, MD,
- Marie Bourgeois, MD,
- Christine Ioos, MD,
- Cyril Gitiaux, MD,
- Cécile Laroche, MD,
- Mathieu Milh, MD, PhD,
- Vincent Des Portes, MD, PhD,
- Alexis Arzimanoglou, MD,
- Agathe Roubertie, MD, PhD;
- the AHC–Movement Disorder Study Group
- Eleni Panagiotakaki, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Diane Doummar, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Erika Nogue, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nicolas Nagot, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gaetan Lesca, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Florence Riant, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sophie Nicole, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Association Française contre la myopathie (Research grant without salaries)Fondation Maladies Rares (Research grant without salaries)
NONE
NONE
NONE
NONE
NONE
NONE
- Charlene Delaygue, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marie Anne Barthez, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marie Cécile Nassogne, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Anne Dusser, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Louis Vallée, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thierry Billette, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marie Bourgeois, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Christine Ioos, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cyril Gitiaux, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cécile Laroche, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mathieu Milh, MD, PhD,
NONE
NONE
Honoraria from Shire, Eisai, GW pharma, Liva nova and from Cyberonics (symposium).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
ANR 2014, ANR 2019
JED Fondation
NONE
NONE
NONE
NONE
NONE
NONE
- Vincent Des Portes, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alexis Arzimanoglou, MD,
(1) Biomarin; (2) Eisai; (3) GW Pharma; (4) Shire; (5) Takeda; (6) UCB; (7) ZOGENIX.
NONE
(1) BIOMARIN; (2) EISAI; (3) GW Pharma; (4) SHIRE; (5) UCB; (§) ZOGENIX.
(1) EPILEPTIC DISORDERS, Educational Journal of the International League Against Epilepsy; Editor-in-Chief; 2004; (2) EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY; Associate Editor; 2012
NONE
NONE
NONE
(1) Biomarin; (2) Eisai; (3) GW Pharma; (4) Shire; (5) Takeda; (6) UCB; (7) ZOGENIX.
NONE
NONE
NONE
(1) UCB; (2) CAIXA FOUNDATION;
NONE
ANR 2014, ANR 2019
JED Fondation
NONE
NONE
NONE
NONE
NONE
NONE
- Agathe Roubertie, MD, PhD;
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- the AHC–Movement Disorder Study Group
- From Sleep Disorders and Functional Neurology (E.P., A.A.), Department of Paediatric Clinical Epileptology, University Hospitals of Lyon, member of the ERN EpiCARE; Service de Neurologie Pédiatrique (D.D., T.B.), Hôpital Trousseau, APHP, Paris; Centre d’Investigation Clinique (E.N., N.N.), CHU Montpellier; Department of Medical Genetics (G.L.), Centre de Biologie Est, Lyon University Hospital, Hospices Civils de Lyon, member of the ERN EpiCARE; Laboratoire de Génétique (F.R.), Groupe Hospitalier Lariboisière-Fernand Widal AP-HP, Paris; IGF (S.N.), Univ Montpellier, CNRS, INSERM; Département de Neuropédiatrie (C.D., A.R.), CHU Gui de Chauliac, Montpellier; Service de Neuropédiatrie et Handicaps (M.A.B.), Hôpital Gatien de Clocheville, CHU Tours, France; Pediatric Neurology Unit (M.C.N.), Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium; Service de Neuropédiatrie (A.D.), CHU de Bicêtre, Kremlin-Bicêtre; Service de Neuropédiatrie (L.V.), CHU Lille; Service de Neurochirurgie Pédiatrique (M.B.), Hôpital Necker-Enfants Malades, APHP, Paris; Service de Neurologie Pédiatrique (C.I.), Hôpital Raymond Poincarré, AP-HP, Garches; Service de Neurophysiologie (C.G.), Hôpital Necker, AP-HP, Paris; Département de Pédiatrie (C.L.), CHU Limoges; Service de Neurologie Pédiatrique (M.M.), CHU Timone Enfants, Marseille; Centre de Référence “Déficiences Intellectuelles de Causes Rares” (V.D.P.), Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, Université de Lyon; and INSERM U 1051 (A.R.), Institut des Neurosciences de Montpellier, France.
- Correspondence
Prof. Roubertie a-roubertie{at}chu-montpellier.fr
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.